Cargando…

Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer's Disease

Alzheimer's disease (AD) is a progressive neurodegenerative disease that primarily manifests as memory deficits and cognitive impairment and has created health challenges for patients and society. In AD, amyloid β-protein (Aβ) induces Toll-like receptor 4 (TLR4) activation in microglia. Activat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Linyu, Xian, Xiaohui, Xu, Guangyu, Tan, Zixuan, Dong, Fang, Zhang, Min, Zhang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420645/ https://www.ncbi.nlm.nih.gov/pubmed/36046763 http://dx.doi.org/10.1155/2022/7924199

Ejemplares similares

Toll-like receptor 2: therapeutic target for gastric carcinogenesis
por: McCormack, William, et al.
Publicado: (2012)

Targeting Toll-Like Receptors: Promising Therapeutic Strategies for the Management of Sepsis-Associated Pathology and Infectious Diseases
por: Savva, Athina, et al.
Publicado: (2013)

Toll‐like receptor 4: A promising therapeutic target for pneumonia caused by Gram‐negative bacteria
por: Ding, Junying, et al.
Publicado: (2019)

Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer
por: Muccioli, Maria, et al.
Publicado: (2012)

Recent clinical trends in Toll‐like receptor targeting therapeutics
por: Anwar, Muhammad Ayaz, et al.
Publicado: (2018)

Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
por: Farooq, Mariya, et al.
Publicado: (2021)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors
por: Abarca-Merlin, D. M., et al.
Publicado: (2019)

Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems
por: Li, Haixia, et al.
Publicado: (2021)

Role of Toll Like Receptor 4 in Alzheimer’s Disease
por: Calvo-Rodriguez, Maria, et al.
Publicado: (2020)

NOD-like receptors mediate homeostatic intestinal epithelial barrier function: promising therapeutic targets for inflammatory bowel disease
por: Zhou, Feng, et al.
Publicado: (2023)

The role of toll-like receptors (TLRs) in pan-cancer
por: Huang, Runzhi, et al.
Publicado: (2022)

Microbiota-gut-brain axis and toll-like receptors in Alzheimer’s disease
por: Lin, Caixiu, et al.
Publicado: (2019)

Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders
por: Ashayeri Ahmadabad, Rezan, et al.
Publicado: (2021)

HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
por: Ren, Wenxuan, et al.
Publicado: (2023)

Toll-like receptors in cardiac hypertrophy
por: Zhang, Yanan, et al.
Publicado: (2023)

Toll-Like Receptor Signaling Pathways—Therapeutic Opportunities
por: Zhu, Jiankun, et al.
Publicado: (2010)

Targeting Toll-Like Receptors for Treatment of SLE
por: Horton, Christopher G., et al.
Publicado: (2010)

Sequence Variants of Toll Like Receptor 4 and Late-Onset Alzheimer's Disease
por: Chen, Yen-Ching, et al.
Publicado: (2012)

Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer’s disease in Han Chinese
por: Wang, Ying-Li, et al.
Publicado: (2013)

Mycobacterial signaling through toll-like receptors
por: Basu, Joyoti, et al.
Publicado: (2012)

Transcutaneous Electrical Nerve Stimulation (TENS) Alleviates Brain Ischemic Injury by Regulating Neuronal Oxidative Stress, Pyroptosis, and Mitophagy
por: Tan, Zixuan, et al.
Publicado: (2023)

Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
por: Gao, Wei, et al.
Publicado: (2017)

Toll-Like Receptors and Prostate Cancer
por: Zhao, Shu, et al.
Publicado: (2014)

Toll‐like receptors in pathogenesis of neurodegenerative diseases and their therapeutic potential
por: Dabi, Yosef Tsegaye, et al.
Publicado: (2023)

Toll-Like Receptors and Myocardial Inflammation
por: Feng, Yan, et al.
Publicado: (2011)

Molecular characteristics and therapeutic implications of Toll-like receptor signaling pathway in melanoma
por: Guan, Hewen, et al.
Publicado: (2023)

Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
por: Muccioli, Maria, et al.
Publicado: (2014)

Faecal and mucosal microbiota in patients with functional gastrointestinal disorders: Correlation with toll-like receptor 2/toll-like receptor 4 expression
por: Dong, Li-Na, et al.
Publicado: (2017)

Association between toll-like receptors 9 (TLR9) gene polymorphism and risk of pulmonary tuberculosis: meta-analysis
por: Chen, Zhi, et al.
Publicado: (2015)

Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
por: Lepper, Philipp M., et al.
Publicado: (2010)

Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling
por: Gosu, Vijayakumar, et al.
Publicado: (2012)

Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
por: Javaid, Nasir, et al.
Publicado: (2019)

Toll-Like Receptors in Atherosclerosis
por: Falck-Hansen, Mika, et al.
Publicado: (2013)

Toll-Like Receptors in Angiogenesis
por: Grote, Karsten, et al.
Publicado: (2011)

Toll-like Receptors and Thrombopoiesis
por: Tang, Xiaoqin, et al.
Publicado: (2023)

Toll-like Receptors and Inflammatory Bowel Disease
por: Lu, Yue, et al.
Publicado: (2018)

Targeting Endothelin in Alzheimer's Disease: A Promising Therapeutic Approach
por: Sharma, Shiwali, et al.
Publicado: (2021)

Targeting and Recognition of Toll-Like Receptors by Plant and Pathogen Lectins
por: Ricci-Azevedo, Rafael, et al.
Publicado: (2017)

Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines
por: Li, Qingjiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t8jgfukvdj9smvvi7kqqed4c2d